GlassScriptPhysician profile
Tiffany M Padilla
NPI 1497765010
$5,971.10
in general payments reported to CMS, 2019-2025
32 companies · $2,230 in 2025
The $2,230 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $524 · 2023: $1,795 · 2024: $1,422 · 2025: $2,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,350 · Education: $96.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,350.44 |
| Education | $96.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,163.31 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $861.48 | 2022-2025 | Ofev, Jascayd, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $731.01 | 2023-2025 | Fasenra, Breztri, Airsupra |
| Genzyme Corporation | $546.80 | 2022-2025 | |
| United Therapeutics Corporation | $278.94 | 2023-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $219.29 | 2023-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $215.30 | 2022-2025 | Acthar |
| Insmed, INC. | $205.37 | 2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $166.71 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| La Jolla Pharmaceutical Company | $164.81 | 2022-2023 | Giapreza |
| Harmony Biosciences LLC | $155.26 | 2023-2025 | Wakix |
| Mylan Specialty L.P. | $154.81 | 2023-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $142.83 | 2025 | Zerbaxa |
| Verona Pharma, INC. | $109.72 | 2025 | Ohtuvayre |
| Vifor Pharma, INC. | $87.22 | 2024-2025 | Zemaira |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $83.98 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $82.99 | 2024-2025 | Glassia |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Grifols USA, LLC | $69.20 | 2022-2024 | Prolastin-C Liquid |
| Electromed, INC. | $68.02 | 2024 | Smartvest |
| Philips North America LLC | $61.60 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Inogen, INC. | $50.41 | 2022-2023 | Inogen At Home Stationary Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Jazz Pharmaceuticals INC. | $49.11 | 2023-2024 | |
| Intuitive Surgical, INC. | $46.33 | 2024 | |
| Amgen INC. | $44.45 | 2023-2024 | Tezspire, Tavneos |
| Bayer Healthcare Pharmaceuticals INC. | $22.48 | 2024 | |
| Pulmonx Corporation | $22.45 | 2024 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Pfizer INC. | $22.32 | 2023 | |
| Ani Pharmaceuticals, INC. | $18.02 | 2025 | Purified Cortrophin Gel |
| 3b Medical, INC. | $16.74 | 2025 | Luna |
| Sandoz INC. | $16.18 | 2025 | Treprostinil |
| Lilly USA, LLC | $14.97 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Padilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.